InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Scott Bizily. Director active across 1 company, notably 4D Molecular Therapeutics, Inc.. In total, 4 filings have been published. History available since 23 June 2026. The latest transaction was filed on 17 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条